![Thomas Bumol](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Bumol
Direktor/Vorstandsmitglied bei
OMEROS CORPORATION
Vermögen: 110 400 $ am 31.05.2026
Profil
Thomas F.
Bumol is currently an Independent Director at Omeros Corp.
since 2019, a Director at Revalesio Corp.
since 2020, a Director at Spine BioPharma, Inc., an Independent Director at Tentarix Biotherapeutics LP since 2022, and a Venture Partner at Samsara BioCapital LLC starting in 2026.
Formerly, Dr. Bumol was a Director at PanTheryx, Inc., Executive Director & Executive Vice President at Allen Institute For Immunology from 2018 to 2022, Senior VP-Biotechnology & Autoimmunity Research at Eli Lilly & Co. from 2015 to 2017, President at Applied Molecular Evolution, Inc., and Vice President-Research Technologies & Proteins at Lilly Research Laboratories from 2001 to 2012.
Education includes an undergraduate degree from the University of Michigan in 1975 and a doctorate from the University of Minnesota in 1980.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OMEROS CORPORATION 0,01 % | 18.06.2026 | 10.000 ( 0,01 % ) | 110 400 $ | 31.05.2026 |
Aktive Positionen von Thomas Bumol
| Unternehmen | Position | Beginn |
|---|---|---|
| OMEROS CORPORATION | Direktor/Vorstandsmitglied | 09.02.2019 |
Revalesio Corp.
 Revalesio Corp. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for the treatment of inflammatory diseases | Direktor/Vorstandsmitglied | 01.10.2020 |
Tentarix Biotherapeutics LP
 Tentarix Biotherapeutics LP BiotechnologyHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | 20.05.2022 |
Spine BioPharma LLC
 Spine BioPharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Direktor/Vorstandsmitglied | - |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Private Equity Investor | 01.01.2026 |
Ehemalige bekannte Positionen von Thomas Bumol
| Unternehmen | Position | Ende |
|---|---|---|
Allen Institute For Immunology
 Allen Institute For Immunology Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit bioscience research institute | Direktor/Vorstandsmitglied | 01.08.2022 |
| ELI LILLY AND COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2017 |
PanTheryx, Inc.
 PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional supplements | Direktor/Vorstandsmitglied | - |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Engages in research and develops medicines | Technik-/Wissenschafts-/F&E-Leiter | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Thomas Bumol
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Applied Molecular Evolution, Inc.
 Applied Molecular Evolution, Inc. BiotechnologyHealth Technology Develops and manufactures proteins & genes for commercial purposes | Health Technology |
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
PanTheryx, Inc.
PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional supplements | Health Technology |
Revalesio Corp.
Revalesio Corp. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for the treatment of inflammatory diseases | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Engages in research and develops medicines | Commercial Services |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Allen Institute For Immunology
Allen Institute For Immunology Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit bioscience research institute | Commercial Services |
Spine BioPharma LLC
Spine BioPharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Tentarix Biotherapeutics LP
Tentarix Biotherapeutics LP BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
